FDA clears Abbott CardioMEMS app features for heart failure patients

October 5, 2026 9:00 AM

Abbott (NYSE: ABT) received U.S. Food and Drug Administration approval for updates to its CardioMEMS HF System that allow heart ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found